Provenge - 2/16

Entry	Author	Date	Location
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer	Luke Timmerman	05/24/11	Seattle
The Resurgence of Gene and Cell Therapy	Barrie Carter	05/16/11	Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News	Luke Timmerman	05/05/11	Seattle
Dendreon Gets $28M Revenue in Q1	Luke Timmerman	05/02/11	Seattle
Dendreon Faces Internet-Fueled Shareholder Uprising, Led by a Little Guy in Kansas	Luke Timmerman	04/01/11	Seattle
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug	Luke Timmerman	03/30/11	Seattle
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again	Luke Timmerman	03/21/11	National
Dendreon’s Warhorse, Chief Scientific Officer Dave Urdal, To Retire at Year-End	Luke Timmerman	03/11/11	Seattle
Dendreon Gets FDA Green Light for NJ Factory	Luke Timmerman	03/10/11	Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building	Luke Timmerman	03/01/11	Seattle
Dendreon Scopes Out Downtown Seattle Headquarters	Luke Timmerman	02/18/11	Seattle
Dendreon Rakes in $540M to Seize Opportunity for Provenge in U.S., Europe	Luke Timmerman	01/14/11	Seattle
Dendreon Seeks $500M Debt Deal	Luke Timmerman	01/13/11	Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News	Luke Timmerman	01/13/11	Seattle
Dendreon Plans to Go It Alone in Europe, Build Provenge Factory in Germany	Luke Timmerman	01/07/11	Seattle
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011	N. Anthony Coles	12/30/10	San Francisco
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News	Luke Timmerman	11/24/10	Seattle
Dendreon’s Commercial Point Man Exits In Year One of Provenge Launch	Luke Timmerman	11/18/10	Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	11/18/10	Seattle
Dendreon Passes Medicare Panel’s Questions About Provenge Effectiveness	Luke Timmerman	11/17/10	Seattle
Dendreon Prepares to Take Some Heat in the Other Washington Over Cancer Drug Prices	Luke Timmerman	11/16/10	Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	11/11/10	Seattle
Dendreon Seeks OK to Grow NJ Factory	Luke Timmerman	11/10/10	Seattle
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News	Luke Timmerman	11/04/10	Seattle
Dendreon, Hemmed in By Tight Supply, Sees $350M to $400M in 2011 Sales Plan	Luke Timmerman	11/03/10	Seattle
Dendreon’s Provenge Launch Story Enters Second Chapter, With Today’s Earnings Call	Luke Timmerman	11/03/10	Seattle
Dendreon CEO at WBBA Meeting: State Should Reject Income Tax, Inspire Young Scientists	Luke Timmerman	10/22/10	Seattle
Kaleetan Seeks to Stand on Dendreon’s Shoulders, With Immune Therapy for Cancer	Luke Timmerman	08/09/10	Seattle
Dendreon Shows Provenge Demand, Seattle Genetics Inks Big Deal, Corey Gets Top Hutch Job, & More Seattle-Area Life Sciences News	Luke Timmerman	08/05/10	Seattle
Dendreon Conference Call Notebook: The Tale of a Provenge Launch Ramp-Up	Luke Timmerman	08/03/10	Seattle
Page 2 of 6	« previous page · next page »

Entry

Author

Date

Location

Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer

Luke Timmerman

05/24/11

Seattle

The Resurgence of Gene and Cell Therapy

Barrie Carter

05/16/11

Seattle